Kentucky BioProcessing, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Owensboro KY United States (2006)

Organization Overview

First Clinical Trial
2020
NCT04439695
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Kentucky BioProcessing | Kentucky BioProcessing, Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

kbp-covid-19 (1 trial)

Drugs in Phase 1 Trials (1)

inactivated influenza vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2